Trials / Completed
CompletedNCT05292534
Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Sonova AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.
Detailed description
2 groups of adults with hearing loss and chronic bothersome tinnitus and no experience with amplification will participate in a cross over intervention study with 2 conditions of 4 weeks each: 1. fit with hearing aid (HA) amplification-only, and 2. fit with HA amplification with an added sound, returning to their original unaided condition after undergoing the intervention phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hearing aid amplification | Hearing aid will be fit to prescribed participant hearing loss. |
| DEVICE | hearing aid amplification with an added sound | Hearing aid will be fit to prescribed participant hearing loss and an added sound will be activated. |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2023-09-20
- Completion
- 2023-09-20
- First posted
- 2022-03-23
- Last updated
- 2024-07-05
- Results posted
- 2024-07-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05292534. Inclusion in this directory is not an endorsement.